One Stop Solution For In-Depth Market Research Reports


Home    >    HEALTHCARE AND PHARMACEUTICALS   >   Spatial Genomics & Transcriptomics Market

[ 英語タイトル ] Spatial Genomics & Transcriptomics Market- Growth, Trends, and Forecast (2020 - 2025)

Product Code : MDHC0084203
Survey : Mordor Intelligence
Publish On : November, 2020
Number of Pages : 112
Category : Healthcare and Pharmaceuticals
Study Area : Global
Report format : PDF
Sales price option (consumption tax not included)
Single User USD4250 / Question Form
5 User USD4750 / Question Form
Enterprise User USD7500 / Question Form
- 10x Genomics
- Dovetail Genomics
- Illumina, Inc.
- S2 Genomics, Inc.
- NanoString Technologies, Inc.
- Seven Bridges Genomics
- Horizon Discovery Group plc
- Advanced Cell Diagnostics, Inc. (ACD)

[Report Description]

Market Overview

The spatial genomics & transcriptomics market will show rapid growth due to the emerging potential of spatial genomic analysis as a cancer diagnostic tool, and the advent of the fourth generation of sequencing.
The spatial patterns of the genome have been identified for treating several medical conditions, which has resulted in the implementation of spatial information as a diagnostic biomarker for various diseases. There is a growing demand for biomarkers, which enables differentiation of benign tumors from the malignant tumor with higher accuracy and therefore boosts the demand for spatial genomic analysis as a cancer diagnostic tool. Therefore the cumulative demand for robust cancer diagnostic solutions helps in the growth of the overall market.

There are also various developments seen in genetic instruments as well as increasing investment in genomics and transcriptomic research that are found to be important drivers of market growth. In addition, the new and start-up genomic businesses are found working to meet the growing demand for sophisticated methods to study spatial patterns through new goods.

Scope of the Report

Spatial genomics & transcriptomics is a relatively new discipline that involves the determination of high-throughput data pertaining to the organizational structure of cell content from tissue and cell specimens. The spacious genomics & transcriptomy enables researchers to see not just what is in a cell, but how the cells are organized in relation to each other. Spatial genomics & transcriptomics includes transcriptoma exploration and assortment. It has various applications, mainly in the field of molecular genetics.

Key Market Trends

Consumables Segment is Expected to Witness Healthy Growth During the Forecast Period

Consumables segment has been estimated to show a healthy growth rate due to the factors such as wide availability of reagents and kits, increased usage rate, and frequent purchase of consumables, which results in higher penetration of consumables to run the instruments. Therefore due to the elevated penetration of products and the broad accessibility of reagents and kits for conducting studies, consumables are found to grow rapidly in the future.

North America is Anticipated to Dominate the Spatial Genomics & Transcriptomics Market

North America is found dominating the market by the revenue due to the increasing adoption of solutions for spatial profiling in cancer research, coupled with a rising focus on genomics-based R&D. The increasing investment by both government and private companies in the US region also helps in the growth of the overall market. The largest share is attributed to massive investments in cancer research to address the high demand for advanced diagnostic & treatment methods in the U.S.
Asia-Pacific is expected to exhibit the fastest growth over the forecast period. Developing economies in the region are equipped with inexpensive manufacturing & operating units, thereby increasing the geographical expansion of companies operating from established regions.

Competitive Landscape

There has been a presence of a considerable number of companies that are significantly contributing to market growth which include 10x Genomics, Dovetail Genomics, Illumina, S2 Genomics, NanoString Technologies, and Seven Bridges Genomic. These manufacturers are found offering technologically advanced genomics-based techniques and platforms for a better understanding of disease biology and the introduction of novel therapeutics.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- Report customization as per the client's requirements
- 3 months of analyst support

1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study



4.1 Market Overview
4.2 Market Drivers
4.2.1 Emerging potential of spatial genomic analysis as cancer diagnostic tool
4.2.2 Emerging players can boost the market competitiveness
4.2.3 Advent of fourth generation of sequencing
4.3 Market Restraints
4.3.1 Slow implementation of technology
4.3.2 Well-established workflows for conventional genomics & transcriptomics analysis
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5.1 By Technology
5.1.1 Spatial Transcriptomics Sequencing-Based Methods IHC Microscopy-based RNA Imaging Techniques
5.1.2 Spatial Genomics Microscopy-based Live DNA Imaging FISH Massively-Parallel Sequencing Genome Perturbation Tools Biochemical Techniques Others
5.2 By Product
5.2.1 Instruments
5.2.2 Software
5.2.3 Consumables
5.3 By End-User
5.3.1 Pharmaceutical Manufacturer
5.3.2 Academic Customers
5.3.3 Diagnostic Customers
5.4 Geography
5.4.1 North America United States Canada Mexico
5.4.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.4.3 Asia Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.4.4 Middle East and Africa GCC South Africa Rest of Middle East and Africa
5.4.5 South America Brazil Argentina Rest of South America

6.1 Company Profiles
6.1.1 10x Genomics
6.1.3 Dovetail Genomics
6.1.4 Illumina, Inc.
6.1.5 S2 Genomics, Inc.
6.1.6 NanoString Technologies, Inc.
6.1.7 Seven Bridges Genomics
6.1.8 Horizon Discovery Group plc
6.1.9 Advanced Cell Diagnostics, Inc. (ACD)




Recommended reports